Business Description
Peak Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US70470P1084
Description
Peak Bio Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics addressing unmet needs in the areas of oncology and inflammation.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -11.63 | |||||
Debt-to-Equity | -0.56 | |||||
Debt-to-EBITDA | -0.6 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -84.97 | |||||
Beneish M-Score | -142.67 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.81 | |||||
14-Day RSI | 90.71 | |||||
6-1 Month Momentum % | -96.75 | |||||
12-1 Month Momentum % | -98.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5168.15 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -2238.98 | |||||
Net Margin % | -3133.72 | |||||
FCF Margin % | -1149.34 | |||||
ROA % | -133.24 | |||||
ROIC % | -64.79 | |||||
ROC (Joel Greenblatt) % | -1419.96 | |||||
ROCE % | -1653.38 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.31 | |||||
EV-to-EBIT | -0.59 | |||||
EV-to-EBITDA | -0.6 | |||||
EV-to-Revenue | 16.23 | |||||
EV-to-FCF | -1.41 | |||||
Earnings Yield (Greenblatt) % | -169.49 | |||||
FCF Yield % | -3147.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PKBO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Peak Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.608 | ||
EPS (TTM) ($) | -0.961 | ||
Beta | 0 | ||
Volatility % | 346.01 | ||
14-Day RSI | 90.71 | ||
14-Day ATR ($) | 0.000068 | ||
20-Day SMA ($) | 0.0089 | ||
12-1 Month Momentum % | -98.96 | ||
52-Week Range ($) | 0.002 - 0.84 | ||
Shares Outstanding (Mil) | 23.12 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Peak Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Peak Bio Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Peak Bio Inc Frequently Asked Questions
What is Peak Bio Inc(PKBO)'s stock price today?
The current price of PKBO is $0.01. The 52 week high of PKBO is $0.84 and 52 week low is $0.00.
When is next earnings date of Peak Bio Inc(PKBO)?
The next earnings date of Peak Bio Inc(PKBO) is .
Does Peak Bio Inc(PKBO) pay dividends? If so, how much?
Peak Bio Inc(PKBO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |